The 2024 Avoca Quality Consortium Summit is a Virtual Event that will be held May 14-15

Princeton, New Jersey – The industry is undergoing a transformation. With increasingly complex trial designs, tighter timelines, multiple systems requiring collaboration and integration, financial pressures, and fewer personnel resources, we need to accomplish more in less time.

It’s imperative to re-evaluate traditional approaches to clinical trials and make dynamic shifts.

This year’s industry-wide AQC Summit features thought leaders and executive panels sharing experiences, insights, ideas, and actions the clinical trial industry can take to transform and thrive.

For further details about the summit, including registration, please click here.

 

Session Topics

 

MAY 14 

Artificial Intelligence Discussion: How to leverage AI to maximize time 

Advances in AI technology provide numerous opportunities for maximizing time in a clinical research environment impacted by a discerning financial environment. Join this executive panel as they discuss where the application of AI can be leveraged to alleviate current challenges.

Sustainability Discussion:  The Impact of Clinical Trials on the Global Climate Crisis and the Imperative for Timely Change  

Addressing the pressing environmental impact of clinical trial execution is crucial for sustainable development. Recognizing the need for low-carbon clinical trials is a positive step toward mitigating the industry’s contribution to climate change.

In this session, we’ll examine the progress the industry has made in recent years and strategies for conducting low carbon clinical trials.

Avoca Industry Research: ICH E6 R3 Impact & Preparedness  

Are you getting ready? Here is what we’ve learned from Avoca’s 2024 Annual  Industry Survey where we have captured data from Sponsors, CROs, Providers, and Site Staff regarding the anticipated impact of the potential changes in regulatory guidance under ICH E6 (R3), and the necessary preparation planned or already underway.

In this session, Avoca’s Crissy MacDonald will share key findings from this research.

 

MAY 15 

Challenges and Solutions for Advancing Diversity, Equity and Inclusion  

Inadequate diversity in clinical trials is a significant issue that has far-reaching consequences on the quality, cost, and safety of healthcare interventions. Recognizing and addressing the barriers to diverse participation is crucial for ensuring that clinical research is representative and applicable to all patient populations.

The panel will address the challenges of achieving patient diversity in clinical research, explore the potential consequences of inadequate representation, and discuss strategies to foster patient diversity in the early stages of study development.

Quality Discussion: Do we need to slow down to speed up?  Leveraging ICH E6 (R3) to drive efficiency in the clinical trial process  

ICH E6 (R3) highlights the need for thoughtful study design, careful assessment of critical to quality factors, and implementation of risk-proportionate approaches.  This takes time, usually at the beginning of the study, where the impulse is to move fast.  If we put our attention on the factors that really matter, can we leverage the expectations in ICH E6 (R3) to drive efficiency without impacting quality?

In this session, clinical research thought leaders will share insights and opportunities.

 

Summit at a glance

When: May 14-15 2024

Venue: Virtual event

 

Contact

Andrea Everett

+1 609.252.9020

[email protected]